Markets Courses Calendar News Analysis & Opinion Brokers Advertise

Loading

Loading…

Learn to Lead.

Trading-education courses, live markets, financial news, the economic calendar and broker reviews — in one trusted hub.

Learn

All Courses
Forex
Stocks
Crypto

Markets

Indices
Financial News
Economic Calendar
Analysis & Opinion
Broker Reviews

Account

Log in
Sign up
My Learning
About Us
Contact Us
Advertise

Legal

Terms & Conditions
Privacy Policy
Refund & Cancellation
Risk Disclaimer
Cookie Policy

© 2026 Academiya. All rights reserved.

Terms Privacy Refund Risk Disclaimer Cookies

Risk warning: Trading and investing carry risk of loss. Educational content on Academiya is for learning purposes only and is not financial advice. Market data may be delayed.

Markets today

Financial news

The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.

Updated 30 Jun, 11:00 pm

NASDAQ:AVAVfmp·29 Jun

AeroVironment (NASDAQ: AVAV) Reports Strong Quarterly Results Amidst Growing Drone Technology Demand

AeroVironment (NASDAQ: AVAV) exceeded analyst expectations with strong quarterly earnings per share (EPS) of $1.84 and robust revenue of $641.62 million . The company experienced substantial growth, with revenue more than doubling year-over-year and its stock price increasing by

NYSE:FDSfmp·29 Jun

FactSet Research Systems Inc. (NYSE:FDS) Q3 Earnings Preview: Growth, Financial Health, and Analyst Outlook

FactSet Research Systems Inc. (NYSE:FDS) is projected to report strong third-quarter earnings with an estimated EPS of $4.44 and revenue of $617.91 million , reflecting year-over-year growth. The company's growth is bolstered by robust regional performance in the Americas and Asi

NASDAQ:PYPLfmp·29 Jun

PayPal (NASDAQ: PYPL) Faces Growth Challenges Amidst Analyst Downgrade

Analyst firm Piper Sandler reduced its price target for PayPal, maintaining a Neutral rating due to cautious sentiment. PayPal is facing significant growth challenges, with slowing revenue growth and modest daily active user increases, contributing to a substantial stock decline

NASDAQ:AVOfmp·29 Jun

Mission Produce (NASDAQ:AVO) Insider Trades: CFO Sells, Director Buys Amidst Analyst Optimism

Mixed Insider Activity: While the CFO sold shares, a director made significant open-market purchases, suggesting differing internal views or strategic moves within the company. Post-Earnings Buying Signals Confidence: A director's substantial share purchases followed a Q2 earning

NYSE:EVMNfmp·29 Jun

Market Movers: Analyzing Today's Top Stock Declines and Inverse ETF Performance

Clinical Trial Impact: Biotech stock valuations, exemplified by Evommune, Inc. (NASDAQ: EVMN) , are highly susceptible to clinical trial results. Company-Specific News: Significant stock declines can be triggered by specific company announcements or developments, as seen with Fre

NASDAQ:UPCfmp·29 Jun

Top Stock Gainers: Strategic Corporate Actions Drive Market Surges

Acquisitions and successful financing are major catalysts for significant stock price increases. Leadership appointments can positively influence investor confidence and company valuation. Leveraged ETFs can amplify returns during broader market rallies, reflecting wider market t

NYSE:MRKfmp·29 Jun

Merck & Co., Inc. (NYSE: MRK) Stock Analysis: Strong Buy Sentiment and Upward Potential

Strong Analyst Sentiment : Merck & Co., Inc. (NYSE: MRK) holds an average brokerage recommendation of 1.73 , indicating a "Strong Buy" to "Buy" rating for the pharmaceutical stock. Increased Price Target : Scotiabank raised its price target for Merck to $155 , signaling increased

NYSE:NKEfmp·29 Jun

NIKE, Inc. (NYSE: NKE) Stock Analysis: Navigating Q4 Forecasts, Market Challenges, and Analyst Sentiment

The consensus price target for Nike has significantly decreased over the past year, reflecting adjusted expectations due to recent performance and market conditions. Analysts project a notable decline in Nike's Q4 revenue, operating income, and EPS, indicating potential headwinds

NASDAQ:VRDNfmp·29 Jun

Wedbush Raises Price Target for Viridian Therapeutics (NASDAQ: VRDN) Following Lumvoa FDA Approval

Wedbush analyst Laura Chico has increased her price target for Viridian Therapeutics to $43 , signaling strong confidence in the biopharmaceutical company's future. The U.S. Food and Drug Administration (FDA) has approved Viridian Therapeutics' new drug, Lumvoa, for Thyroid Eye D

NYSE:MRKfmp·29 Jun

Merck (NYSE: MRK) Stock: Analysts Raise Price Target and Maintain Outperform Rating

Scotiabank raised its price target for Merck to $155.00 from $136.00 , maintaining an "Outperform" rating. The wider analyst community, including Zacks Investment Research, gives Merck an average brokerage recommendation of 1.73 , indicating a strong "Buy" consensus. Merck's stoc

NASDAQ:RKLBfmp·29 Jun

Analyst Raises Rocket Lab (NASDAQ: RKLB) Price Target to $120 Following Transformative Iridium Acquisition

Analyst Jeff Van Rhee of Craig-Hallum has raised the price target for Rocket Lab (NASDAQ: RKLB) to $120.00 , signaling strong confidence in the company's future. Rocket Lab is set to acquire Iridium Communications (NASDAQ: IRDM) in an approximately $8.00 billion cash-and-stock de

NASDAQ:PRGSfmp·29 Jun

Progress Software Corporation (NASDAQ: PRGS) Q2 2026 Earnings Preview: Key Financials and Outlook

Earnings Growth Expected: Analysts project an increase in earnings per share and revenue for Progress Software's upcoming quarterly report. Positive Stock Momentum: The company's shares have shown recent strength, with a notable 11.2% surge in a recent trading session. Financial

NYSE:UBSfmp·29 Jun

UBS (NYSE: UBS) Outlook: Deutsche Bank Rating, Wealth Management Growth, and Regulatory Challenges

Deutsche Bank's Positive Outlook: The bank reiterated a "Buy" rating for UBS, raising its price target to CHF 45 . Strategic U.S. Wealth Management Expansion: UBS is growing its presence in the U.S. by adding new financial advisor teams managing over $2.00 billion in assets. Evol

NASDAQ:MNDRfmp·29 Jun

Mobile-health Network Solutions (NASDAQ: MNDR) Implements Reverse Stock Split: What Investors Need to Know

Mobile-health Network Solutions (NASDAQ: MNDR) executed a one-for-six reverse stock split on June 29, 2026, to increase its share price and maintain its Nasdaq listing. The reverse split reduced outstanding Class A Ordinary Shares from approximately 5.33 million to about 888,592

NYSE:LTHfmp·29 Jun

Life Time Group (NYSE: LTH) Stock Gains Momentum with Price Target Hike and Expansion

Jefferies increased its price target for Life Time Group to $51.00 , suggesting a 24.9% potential upside. Life Time Group shares have gained 31.2% year-to-date, significantly outperforming the broader Zacks Consumer Discretionary sector. The company consistently beats earnings es

NASDAQ:IRDMfmp·29 Jun

Iridium Communications (NASDAQ:IRDM) Downgraded by Oppenheimer Amid Rocket Lab Acquisition

Iridium Communications (NASDAQ:IRDM) received a "Perform" rating downgrade from Oppenheimer, shifting from "Outperform," following its acquisition by Rocket Lab. Rocket Lab is acquiring Iridium Communications in a significant cash-and-stock deal valued at approximately $8 billion

NASDAQ:HONfmp·29 Jun

Honeywell Technologies (NASDAQ: HON) Undergoes Major Restructuring with Strategic Spin-Offs and Reverse Stock Split

Honeywell Technologies is undergoing a significant restructuring, spinning off business segments into independent entities like Honeywell Aerospace and Solstice Advanced Materials to enhance focus and flexibility. A 1-for-2 reverse stock split for Honeywell Technologies is effect

NASDAQ:ACADfmp·29 Jun

Deutsche Bank Raises Acadia Pharmaceuticals (NASDAQ: ACAD) Price Target on DAYBU Approval Hopes

Analyst David Hoang of Deutsche Bank has raised the price target for Acadia Pharmaceuticals (NASDAQ: ACAD) to $37.00 , citing positive developments. The European Medicines Agency (CHMP) has recommended the approval of Acadia Pharmaceuticals' drug, DAYBU, for Rett syndrome, markin

1…121314…34

From Investing.com

Earnings call transcript: Euroapi H1 2026 loss widens as stock sinks 26%Investing.com10m ago
POSCO Q2 2026 slides: lithium turns profitable, operating margin expandsInvesting.com11m ago
Form 4 Newmont Goldcorp Corp For: 30 JulyInvesting.com12m ago
Mizuho Q1 profit jumps 45%, hikes annual forecastInvesting.com13m ago
Spain’s economic growth accelerates to 0.7% in second quarterReuters14m ago
Ayvens reports Q2 profit miss on used car weaknessInvesting.com15m ago
With fields destroyed and hives lost, Gaza’s beekeepers struggle to start overReuters15m ago
Drax confirms 2026 EBITDA outlook, sets 2029 target rangeInvesting.com15m ago
Earnings call transcript: Waaree Energies posts strong Q1 2026 growth, shares fall 4.3%Investing.com15m ago
Russian strikes on Ukraine kill 8; Poland scrambles fighter jetsReuters15m ago

Headlines provided by Investing.com

Go deeper

Turn headlines into edge

General
LEARN TO TRADE LIKE A PRO Master Institutional Trading
$2505.0
General
LEARN TO TRADE LIKE A PRO(R) Master Institutional Trading
$150

Browse all courses